Ubis (Asia) Past Earnings Performance
Past criteria checks 0/6
Ubis (Asia)'s earnings have been declining at an average annual rate of -55.3%, while the Chemicals industry saw earnings growing at 8.6% annually. Revenues have been growing at an average rate of 1.6% per year.
Key information
-55.3%
Earnings growth rate
-54.4%
EPS growth rate
| Chemicals Industry Growth | 8.0% |
| Revenue growth rate | 1.6% |
| Return on equity | -11.8% |
| Net Margin | -8.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Ubis (Asia) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 888 | -74 | 256 | 0 |
| 30 Sep 23 | 915 | -103 | 260 | 0 |
| 30 Jun 23 | 967 | -56 | 235 | 0 |
| 31 Mar 23 | 976 | -29 | 220 | 0 |
| 31 Dec 22 | 1,043 | -20 | 226 | 0 |
| 30 Sep 22 | 1,084 | 12 | 217 | 0 |
| 30 Jun 22 | 1,092 | 2 | 220 | 0 |
| 31 Mar 22 | 1,151 | 26 | 224 | 0 |
| 31 Dec 21 | 1,159 | 55 | 222 | 0 |
| 30 Sep 21 | 1,176 | 70 | 258 | 0 |
| 30 Jun 21 | 1,157 | 109 | 252 | 0 |
| 31 Mar 21 | 1,082 | 107 | 246 | 0 |
| 31 Dec 20 | 1,023 | 120 | 231 | 0 |
| 30 Sep 20 | 956 | 129 | 204 | 0 |
| 30 Jun 20 | 913 | 106 | 193 | 0 |
| 31 Mar 20 | 887 | 104 | 183 | 0 |
| 31 Dec 19 | 911 | 107 | 180 | 0 |
| 30 Sep 19 | 935 | 125 | 171 | 0 |
| 30 Jun 19 | 961 | 130 | 169 | 0 |
| 31 Mar 19 | 953 | 137 | 169 | 0 |
| 31 Dec 18 | 929 | 129 | 168 | 0 |
| 30 Sep 18 | 901 | 112 | 173 | 0 |
| 30 Jun 18 | 838 | 99 | 168 | 0 |
| 31 Mar 18 | 839 | -230 | 490 | 0 |
| 31 Dec 17 | 837 | -236 | 493 | 0 |
| 30 Sep 17 | 847 | -213 | 489 | 0 |
| 30 Jun 17 | 889 | -204 | 501 | 0 |
| 31 Mar 17 | 878 | 120 | 175 | 0 |
| 31 Dec 16 | 849 | 113 | 186 | 0 |
| 30 Sep 16 | 823 | 95 | 186 | 0 |
| 30 Jun 16 | 799 | 101 | 189 | 0 |
| 31 Mar 16 | 796 | 104 | 188 | 0 |
| 31 Dec 15 | 827 | 110 | 181 | 0 |
| 30 Sep 15 | 861 | 118 | 189 | 0 |
| 30 Jun 15 | 893 | 97 | 199 | 0 |
| 31 Mar 15 | 893 | 94 | 203 | 0 |
| 31 Dec 14 | 848 | 85 | 199 | 0 |
| 30 Sep 14 | 792 | 75 | 192 | 0 |
| 30 Jun 14 | 727 | 87 | 167 | 0 |
| 31 Mar 14 | 704 | 81 | 160 | 0 |
| 31 Dec 13 | 711 | 87 | 153 | 0 |
| 30 Sep 13 | 737 | 88 | 151 | 0 |
| 30 Jun 13 | 741 | 81 | 150 | 0 |
Quality Earnings: UBIS-W1-R is currently unprofitable.
Growing Profit Margin: UBIS-W1-R is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UBIS-W1-R is unprofitable, and losses have increased over the past 5 years at a rate of 55.3% per year.
Accelerating Growth: Unable to compare UBIS-W1-R's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: UBIS-W1-R is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (10.4%).
Return on Equity
High ROE: UBIS-W1-R has a negative Return on Equity (-11.79%), as it is currently unprofitable.